Literature DB >> 1924138

Variable glyceryl dinitrate formation following infusions of glyceryl trinitrate at different vascular sites in the rat.

E Nakashima1, D T Lau, L Z Benet.   

Abstract

The availability of glyceryl trinitrate (GTN) and the differential formation of dinitrate metabolites (GDNs) in various organs as a function of routes of administration were investigated in the rat. GTN was infused at 2.0 micrograms/min via the left femoral vein (LFV), left external jugular vein (LJV), left femoral artery (LFA), and hepatic portal vein (HPV). Blood concentrations of GTN and GDNs were measured in femoral arterial samples. Different infusions yielded GTN steady-state concentrations in the following rank order: LJV greater than or equal to LFV greater than LFA greater than or equal to HPV. Furthermore, the GDN formation ratios (1,2-GDN/1,3-GDN) are different: LFV greater than LJV greater than LFA greater than HPV. The availabilities of GTN through the leg, vein, and liver were derived. GTN is significantly extracted and metabolized in these organs, and the leg and the vein prefer 1,2-GDN formation, while the liver forms 1,3-GDN predominantly.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924138     DOI: 10.1023/a:1015851412175

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Mechanism of glyceryl trinitrate-induced vasodilation. I. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta.

Authors:  J F Brien; B E McLaughlin; S M Kobus; J H Kawamoto; K Nakatsu; G S Marks
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

2.  Differential formation of dinitrate metabolites from glyceryl trinitrate in subcellular fractions of rabbit liver.

Authors:  D T Lau; L Z Benet
Journal:  Biochem Pharmacol       Date:  1989-02-01       Impact factor: 5.858

3.  Differential biotransformation of glyceryl trinitrate by red blood cell-supernatant fraction and pulmonary vein homogenate.

Authors:  G S Marks; B E McLaughlin; H F MacMillan; K Nakatsu; J F Brien
Journal:  Can J Physiol Pharmacol       Date:  1989-05       Impact factor: 2.273

4.  Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.

Authors:  H L Fung; H Ogata; A Kamiya; G A Maier
Journal:  J Pharm Sci       Date:  1984-07       Impact factor: 3.534

Review 5.  Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.

Authors:  U Thadani; T Whitsett
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

6.  Simultaneous determination of nitroglycerin and its dinitrate metabolites by capillary gas chromatography with electron-capture detection.

Authors:  F W Lee; N Watari; J Rigod; L Z Benet
Journal:  J Chromatogr       Date:  1988-04-29

7.  Pharmacokinetic studies of the nitroglycerin metabolites, 1,2- and 1,3- glyceryl dinitrates, in the rat.

Authors:  D T Lau; M Gumbleton; C Labisch; L Z Benet
Journal:  Biopharm Drug Dispos       Date:  1991-04       Impact factor: 1.627

8.  Nitroglycerin metabolism in subcellular fractions of rabbit liver. Dose dependency of glyceryl dinitrate formation and possible involvement of multiple isozymes of glutathione S-transferases.

Authors:  D T Lau; L Z Benet
Journal:  Drug Metab Dispos       Date:  1990 May-Jun       Impact factor: 3.922

9.  Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects.

Authors:  E F McNiff; A Yacobi; F M Young-Chang; L H Golden; A Goldfarb; H L Fung
Journal:  J Pharm Sci       Date:  1981-09       Impact factor: 3.534

10.  Nitroglycerin disposition in human blood.

Authors:  P A Cossum; M S Roberts
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more
  1 in total

Review 1.  Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Authors:  Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharm Sci       Date:  2013-05-13       Impact factor: 3.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.